Abstract: Development of rapid and sensitive techniques for detection of B. pseudomallei is an important aim for public health. Here we report a B. pseudomallei specific SYBR Green-based real time PCR targeting a species specific toxin gene. The assay is able to detect 1-2 genome equivalents of B. pseudomallei.
INTRODUCTION
The genus Burkholderia comprises more than 20 validly named species. However, only 2 species are frequently encountered as human pathogens, B. pseudomallei and B. cepacia complex. Of these two, B. pseudomallei is the most important and is responsible for melioidosis, an infectious disease endemic in Southeast Asia and northern Australia. B. pseudomallei is one of the most important causes of community-acquired septicemia in north-eastern Thailand and the Northern Territory of Australia. A very high mortality rate is seen in patients with septicemic melioidosis and these patients often deteriorate quickly and death often occurs within a few days after infection [1] . It is therefore evident, that early detection of the bacterium is important in clinical diagnosis. In Denmark, we see an increase in the number of B. pseudomallei cases due to travelling to areas, where the bacterium is present. In addition, since the emergence of the bioterror threat, early recognition of a biocrime or bioterrorism event requires rapid and accurate diagnostic methods for detection of B. pseudomallei. As melioidosis is a serious disease and B. Pseudomallei should only be cultured under biosafety level-3 (BSL-3) conditions, fast and safe alternatives to identification by culture are clearly warranted.
Several PCR methods have been described for detecting B. pseudomallei. The targets for these methods include 16S rRNA, 23 S rRNA, 16S-23S intergenic region, a repetitive element, type III secretion system genes, flagellin C and ribosomal protein subunit S21 [2] [3] [4] [5] [6] [7] . The aim of this study was to develop and evaluate a SYBR Green-based Real Time PCR that could be implemented in the range of existing assays at the Danish National Centre for Biological Defence (NCBD). We therefore searched for B. pseudomallei specific sequences/genes among the already genome-sequenced Burkholderia species in public databases and after identification of potential sequences we designed appropriate PCR primers and tested them in PCR. We started by evaluating the potential of the PCR to amplify all our B. pseudomallei strains. All the strains evaluated in this study are listed in Table 1 . Of the five different strains of B. pseudomallei used in the assay, all gave a positive amplification profile and no amplification was seen from other Burkholderia species (Fig. 1) . When the B. pseudomallei PCR amplicons were run on an agarose gel, the expected 170 bp product was identified (data not shown). The amplicon melting temperatures of the five B. pseudomallei strains was 85.6 to 86 o C.
To determine the sensitivity of the assay using purified genomic DNA, we made 10-fold dilutions ranging from 0.5 ng and down to 5 fg of template DNA (Fig. 2) . The detection limit of the assay was 10 fg of DNA equivalent to 1-2 genomes of B. pseudomallei as calculated from a total genome size of 7.2 Mbp.
To evaluate the specificity of the assay, genomic DNA was extracted from a range of different clinical and reference bacterial strains other than Burkholderia spp. ( Table 1) . Except for the positive control (B. pseudomallei), none of the Fig. (1) . Specificity of the primers tested on a range of different Burkholderia species consisting of B. pseudomallei, B. mallei, B. cepacia and B. vietnamiensis. Only the five different strains of B. pseudomallei used give a positive amplification. Fig. (2) . Amplification curves of different dilutions of B. pseudomallei template ranging from 0.5 ng to 10 fg of DNA.
Fluorescence
Cycle no. Fluorescence other clinical or reference bacterial strains gave any amplification products indication the high degree of specificity of this assay (Fig. 3) . This was to be expected as no significant similarity to the selected gene was found in the databases among the other more than 300 full or partly genomesequenced bacteria.
Due to the high degree of specificity of this SYBR Green assay, we have chosen not to develop it further to a TaqMan assay or similar at this point. However, an added benefit of the SYBR Green assay is the melting curve analysis, which can be used as a confirmation of the right amplicon. In order for the assay to be implemented in the range of existing assays at the Danish National Centre for Biological Defence, we are in the progress of testing its robustness using a variety of environmental samples spiked with B. pseudomallei.
Melioidosis is a very severe and potentially lethal disease often requiring long term antibiotic and surgical treatment. Between one and three Danish patients are now diagnosed with melioidosis each year after returning from areas where the disease is endemic, in particular North-eastern parts of Thailand. Danish diagnostic routine laboratories are not prepared for handling highly contagious BSL-3 organisms such as B. pseudomallei and there is a clear need for the availability of highly specific analyses in a specialised laboratory. The assay described here offers a fast, safe and specific alternative to culture and phenotypic characterisation for the detection of B. pseudomallei in isolates and clinical samples from patients suspected to suffer from melioidosis. Fig. (3) . Specificity of the primers tested on a range of different bacteria other than Burkholderia spp. The bacteria tested are listed in Table  1 . Only B. pseudomallei (positive control, 0.5 ng) gives an amplification product. The other bacteria species do not give amplification above the baseline fluorescence.
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